Cost of prescription drugs on rise

>> ACCORDING TO AARP’S LATEST >> ACCORDING TO AARP’S LATEST
PRESCRIPTION PRICE WAS REPORT >> ACCORDING TO AARP’S LATEST
PRESCRIPTION PRICE WAS REPORT
THE COST OF PRESCRIPTION DRUGS PRESCRIPTION PRICE WAS REPORT
THE COST OF PRESCRIPTION DRUGS
IS RISING AT A HIGHER RATE THAN THE COST OF PRESCRIPTION DRUGS
IS RISING AT A HIGHER RATE THAN
THAT OF GENERAL INFLATION. IS RISING AT A HIGHER RATE THAN
THAT OF GENERAL INFLATION.
>> THAT IS CONTRIBUTING TO A THAT OF GENERAL INFLATION.
>> THAT IS CONTRIBUTING TO A
HEALTHCARE CRISIS THAT >> THAT IS CONTRIBUTING TO A
HEALTHCARE CRISIS THAT
ESPECIALLY AFFECTS OLDER HEALTHCARE CRISIS THAT
ESPECIALLY AFFECTS OLDER
AMERICANS. ESPECIALLY AFFECTS OLDER
AMERICANS.
>> JOINING US NOW TO TALK ABOUT AMERICANS.
>> JOINING US NOW TO TALK ABOUT
THE FINDINGS IN THE REPORT AND >> JOINING US NOW TO TALK ABOUT
THE FINDINGS IN THE REPORT AND
WHAT WE CAN ALL DO TO COMBAT THE FINDINGS IN THE REPORT AND
WHAT WE CAN ALL DO TO COMBAT
THESE RISING COSTS THE DIRECTOR WHAT WE CAN ALL DO TO COMBAT
THESE RISING COSTS THE DIRECTOR
OF HEALTH SERVICES RESEARCH THESE RISING COSTS THE DIRECTOR
OF HEALTH SERVICES RESEARCH
WITH US AND TELL US ABOUT THE OF HEALTH SERVICES RESEARCH
WITH US AND TELL US ABOUT THE
LATEST FINDINGS IN THIS PRICE WITH US AND TELL US ABOUT THE
LATEST FINDINGS IN THIS PRICE
REPORT. LATEST FINDINGS IN THIS PRICE
REPORT.
>> OR LATEST REPORT TOOK A LOOK REPORT.
>> OR LATEST REPORT TOOK A LOOK
IT OVER 700 BY THE USE >> OR LATEST REPORT TOOK A LOOK
IT OVER 700 BY THE USE
PRESCRIPTION DRUGS AND WHAT WE IT OVER 700 BY THE USE
PRESCRIPTION DRUGS AND WHAT WE
FOUND IS ON AVERAGE THE PRICES PRESCRIPTION DRUGS AND WHAT WE
FOUND IS ON AVERAGE THE PRICES
INCREASE AT DOUBLE THE RATE OF FOUND IS ON AVERAGE THE PRICES
INCREASE AT DOUBLE THE RATE OF
INFLATION IN 2017. INCREASE AT DOUBLE THE RATE OF
INFLATION IN 2017.
>> SO WHAT DOES THAT MEAN IN INFLATION IN 2017.
>> SO WHAT DOES THAT MEAN IN
LAYMAN’S TERMS FOR PEOPLE WHO >> SO WHAT DOES THAT MEAN IN
LAYMAN’S TERMS FOR PEOPLE WHO
ARE STRUGGLING TO AFFORD HIS LAYMAN’S TERMS FOR PEOPLE WHO
ARE STRUGGLING TO AFFORD HIS
PRESCRIPTION DRUGS? ARE STRUGGLING TO AFFORD HIS
PRESCRIPTION DRUGS?
>> I THINK THE MOST IMPORTANT PRESCRIPTION DRUGS?
>> I THINK THE MOST IMPORTANT
NUMBER FROM A REPORT THAT WILL >> I THINK THE MOST IMPORTANT
NUMBER FROM A REPORT THAT WILL
REALLY BE RELEVANT TO YOUR NUMBER FROM A REPORT THAT WILL
REALLY BE RELEVANT TO YOUR
VIEWERS AND HOW MUCH THE DRUGS REALLY BE RELEVANT TO YOUR
VIEWERS AND HOW MUCH THE DRUGS
COST AND WHAT WE FOUND IS ON VIEWERS AND HOW MUCH THE DRUGS
COST AND WHAT WE FOUND IS ON
AVERAGE THE PRICE FOR ONE COST AND WHAT WE FOUND IS ON
AVERAGE THE PRICE FOR ONE
PRESCRIPTION DRUG IS NOW AVERAGE THE PRICE FOR ONE
PRESCRIPTION DRUG IS NOW
APPROACHING $20,000 WHICH IS PRESCRIPTION DRUG IS NOW
APPROACHING $20,000 WHICH IS
VERY CLOSE TO THE MEDIAN INCOME APPROACHING $20,000 WHICH IS
VERY CLOSE TO THE MEDIAN INCOME
FOR MEDICARE BENEFICIARIES. VERY CLOSE TO THE MEDIAN INCOME
FOR MEDICARE BENEFICIARIES.
>> WHAT ARE THE BIGGEST ONES. FOR MEDICARE BENEFICIARIES.
>> WHAT ARE THE BIGGEST ONES.
WE’VE TALKED ABOUT INSULIN A >> WHAT ARE THE BIGGEST ONES.
WE’VE TALKED ABOUT INSULIN A
LOT HERE ON OUR SHOW. WE’VE TALKED ABOUT INSULIN A
LOT HERE ON OUR SHOW.
WHICH DRUGS ARE YOU SEEING OR LOT HERE ON OUR SHOW.
WHICH DRUGS ARE YOU SEEING OR
IS IT JUST TOO MANY TO COUNT WHICH DRUGS ARE YOU SEEING OR
IS IT JUST TOO MANY TO COUNT
ARE THE HIGHEST AND MOST IS IT JUST TOO MANY TO COUNT
ARE THE HIGHEST AND MOST
EXPENSIVE. ARE THE HIGHEST AND MOST
EXPENSIVE.
>> YOU MAKE A GOOD POINT. EXPENSIVE.
>> YOU MAKE A GOOD POINT.
UNFORTUNATELY THIS REALLY IS A >> YOU MAKE A GOOD POINT.
UNFORTUNATELY THIS REALLY IS A
PERVASIVE PROBLEM ARE JUST A UNFORTUNATELY THIS REALLY IS A
PERVASIVE PROBLEM ARE JUST A
FEW PRODUCTS BUT A LOT OF PERVASIVE PROBLEM ARE JUST A
FEW PRODUCTS BUT A LOT OF
PRODUCTS. FEW PRODUCTS BUT A LOT OF
PRODUCTS.
THAT SAID WE DO HAVE SOME PRODUCTS.
THAT SAID WE DO HAVE SOME
PRODUCTS WE TOOK A LOOK AT WITH THAT SAID WE DO HAVE SOME
PRODUCTS WE TOOK A LOOK AT WITH
PRICES THAT EXCEED $2000 PER PRODUCTS WE TOOK A LOOK AT WITH
PRICES THAT EXCEED $2000 PER
YEAR SO WE ARE SEEING SOME PRICES THAT EXCEED $2000 PER
YEAR SO WE ARE SEEING SOME
REMARKABLY EXPENSIVE DRUGS OUT YEAR SO WE ARE SEEING SOME
REMARKABLY EXPENSIVE DRUGS OUT
THERE. REMARKABLY EXPENSIVE DRUGS OUT
THERE.
>> SO WHAT CAN YOU DO. THERE.
>> SO WHAT CAN YOU DO.
WHAT HAPPENS WHEN SOMEONE >> SO WHAT CAN YOU DO.
WHAT HAPPENS WHEN SOMEONE
CANNOT AFFORD THESE WHAT HAPPENS WHEN SOMEONE
CANNOT AFFORD THESE
PRESCRIPTIONS? CANNOT AFFORD THESE
PRESCRIPTIONS?
>> UNFORTUNATELY THERE’S A LOT PRESCRIPTIONS?
>> UNFORTUNATELY THERE’S A LOT
OF PEOPLE MAKING HARD CHOICES. >> UNFORTUNATELY THERE’S A LOT
OF PEOPLE MAKING HARD CHOICES.
WE ARE HERE FOR MORE AND MORE OF PEOPLE MAKING HARD CHOICES.
WE ARE HERE FOR MORE AND MORE
PEOPLE HAVING TO CHOOSE FROM WE ARE HERE FOR MORE AND MORE
PEOPLE HAVING TO CHOOSE FROM
PAYING FOR THE PRESCRIPTION PEOPLE HAVING TO CHOOSE FROM
PAYING FOR THE PRESCRIPTION
DRUGS AND PAYING FOR OTHER PAYING FOR THE PRESCRIPTION
DRUGS AND PAYING FOR OTHER
IMPORTANT THINGS LIKE THEIR DRUGS AND PAYING FOR OTHER
IMPORTANT THINGS LIKE THEIR
FOOD. IMPORTANT THINGS LIKE THEIR
FOOD.
UNFORTUNATELY SOME PEOPLE ARE FOOD.
UNFORTUNATELY SOME PEOPLE ARE
OUR WALKING AWAY WHICH COULD UNFORTUNATELY SOME PEOPLE ARE
OUR WALKING AWAY WHICH COULD
HAVE STRONG IMPACT ON THEIR OUR WALKING AWAY WHICH COULD
HAVE STRONG IMPACT ON THEIR
HEALTH AND HEALTHCARE COST ON HAVE STRONG IMPACT ON THEIR
HEALTH AND HEALTHCARE COST ON
THE ROAD. HEALTH AND HEALTHCARE COST ON
THE ROAD.
IT’S NOT A CHOICE WE THINK THE ROAD.
IT’S NOT A CHOICE WE THINK
ANYONE SHOULD BE MAKING. IT’S NOT A CHOICE WE THINK
ANYONE SHOULD BE MAKING.
>> ARE THERE WAYS TO SAVE THAT ANYONE SHOULD BE MAKING.
>> ARE THERE WAYS TO SAVE THAT
MAYBE PEOPLE DO NOT KNOW ABOUT >> ARE THERE WAYS TO SAVE THAT
MAYBE PEOPLE DO NOT KNOW ABOUT
LIKE MAYBE SOME SECRET MAYBE PEOPLE DO NOT KNOW ABOUT
LIKE MAYBE SOME SECRET
DISCOUNTS OR SOMETHING YOU CAN LIKE MAYBE SOME SECRET
DISCOUNTS OR SOMETHING YOU CAN
ASK FOR YOUR PHARMACY OR WAY TO DISCOUNTS OR SOMETHING YOU CAN
ASK FOR YOUR PHARMACY OR WAY TO
PORDER THINGS SAFELY? ASK FOR YOUR PHARMACY OR WAY TO
PORDER THINGS SAFELY?
>> ABSOLUTELY. PORDER THINGS SAFELY?
>> ABSOLUTELY.
I THINK THE MOST IMPORTANT >> ABSOLUTELY.
I THINK THE MOST IMPORTANT
THING THAT ANYONE CAN DO IS I THINK THE MOST IMPORTANT
THING THAT ANYONE CAN DO IS
TALK TO THEIR HEALTHCARE THING THAT ANYONE CAN DO IS
TALK TO THEIR HEALTHCARE
PROVIDER. TALK TO THEIR HEALTHCARE
PROVIDER.
WHETHER THAT IS YOUR DOCTOR OR PROVIDER.
WHETHER THAT IS YOUR DOCTOR OR
AN ALTERNATIVE AVAILABLE THAT WHETHER THAT IS YOUR DOCTOR OR
AN ALTERNATIVE AVAILABLE THAT
HAS MUCH LOWER COST TO YOU. AN ALTERNATIVE AVAILABLE THAT
HAS MUCH LOWER COST TO YOU.
BENEFICIARIES IS THE EXTRA HOLD HAS MUCH LOWER COST TO YOU.
BENEFICIARIES IS THE EXTRA HOLD
PROGRAM THAT CAN GREATLY REDUCE BENEFICIARIES IS THE EXTRA HOLD
PROGRAM THAT CAN GREATLY REDUCE
YOUR PREMIUMS AND OUT-OF-POCKET PROGRAM THAT CAN GREATLY REDUCE
YOUR PREMIUMS AND OUT-OF-POCKET
MANUFACTURE HIM SOME CELLS. YOUR PREMIUMS AND OUT-OF-POCKET
MANUFACTURE HIM SOME CELLS.
A LOT HAVE PATIENT ASSISTANCE MANUFACTURE HIM SOME CELLS.
A LOT HAVE PATIENT ASSISTANCE
PROGRAMS AND IF YOU QUALIFY YOU A LOT HAVE PATIENT ASSISTANCE
PROGRAMS AND IF YOU QUALIFY YOU
CAN GET THEM FOR LOWER COST OR PROGRAMS AND IF YOU QUALIFY YOU
CAN GET THEM FOR LOWER COST OR
FOR FREE. CAN GET THEM FOR LOWER COST OR
FOR FREE.
>> SO WHY ARE WE DEALING WITH FOR FREE.
>> SO WHY ARE WE DEALING WITH
SUCH HIGH DRUG PRICES. >> SO WHY ARE WE DEALING WITH
SUCH HIGH DRUG PRICES.
IS THERE A WAY FOR LAWMAKERS TO SUCH HIGH DRUG PRICES.
IS THERE A WAY FOR LAWMAKERS TO
STEP IN OR A WAY TO GET THINGS IS THERE A WAY FOR LAWMAKERS TO
STEP IN OR A WAY TO GET THINGS
IN WEIGHT MORE REGULATED. STEP IN OR A WAY TO GET THINGS
IN WEIGHT MORE REGULATED.
>> I THINK THE SHORT ANSWER FOR IN WEIGHT MORE REGULATED.
>> I THINK THE SHORT ANSWER FOR
WHY IS BECAUSE WE BEEN GIVEN >> I THINK THE SHORT ANSWER FOR
WHY IS BECAUSE WE BEEN GIVEN
DRUG MANUFACTURERS A LOT OF WHY IS BECAUSE WE BEEN GIVEN
DRUG MANUFACTURERS A LOT OF
PRICING POWER IN UNITED STATES. DRUG MANUFACTURERS A LOT OF
PRICING POWER IN UNITED STATES.
WE ARE SEEING THE REPERCUSSIONS PRICING POWER IN UNITED STATES.
WE ARE SEEING THE REPERCUSSIONS
OF THAT. WE ARE SEEING THE REPERCUSSIONS
OF THAT.
ABORTION PROBABLY LIGHT OF THAT.
ABORTION PROBABLY LIGHT
POLICYMAKERS ARE ALL WORKING ABORTION PROBABLY LIGHT
POLICYMAKERS ARE ALL WORKING
HARD MAKING SOLUTIONS TO THE POLICYMAKERS ARE ALL WORKING
HARD MAKING SOLUTIONS TO THE
PROBLEMS AND SEEING A LOT OF HARD MAKING SOLUTIONS TO THE
PROBLEMS AND SEEING A LOT OF
ACTIVITY IN CONGRESS AND A LOT PROBLEMS AND SEEING A LOT OF
ACTIVITY IN CONGRESS AND A LOT
OF THINGS IN CONGRESS NEGOTIATE ACTIVITY IN CONGRESS AND A LOT
OF THINGS IN CONGRESS NEGOTIATE
ON HALF OF BENEFICIARIES OR OF THINGS IN CONGRESS NEGOTIATE
ON HALF OF BENEFICIARIES OR
COST UNDER MEDICARE PART D. ON HALF OF BENEFICIARIES OR
COST UNDER MEDICARE PART D.
JUST A LOT OF IDEAS OUT THERE COST UNDER MEDICARE PART D.
JUST A LOT OF IDEAS OUT THERE
SO JUST A MATTER OF HOPEFULLY JUST A LOT OF IDEAS OUT THERE
SO JUST A MATTER OF HOPEFULLY
GETTING SOMETHING THROUGH. SO JUST A MATTER OF HOPEFULLY
GETTING SOMETHING THROUGH.
>> OKAY AND WHERE CAN CONSUMERS GETTING SOMETHING THROUGH.
>> OKAY AND WHERE CAN CONSUMERS
GO FOR MORE INFORMATION AND >> OKAY AND WHERE CAN CONSUMERS
GO FOR MORE INFORMATION AND
RESEARCHES AND TOPICS LIKE GO FOR MORE INFORMATION AND
RESEARCHES AND TOPICS LIKE
THESE? RESEARCHES AND TOPICS LIKE
THESE?
>> PEOPLE WHO WANT TO LEARN THESE?
>> PEOPLE WHO WANT TO LEARN
MORE ABOUT THE ISSUE ABOUT >> PEOPLE WHO WANT TO LEARN
MORE ABOUT THE ISSUE ABOUT
AARP’S ONGOING CAMPAIGN AND MORE ABOUT THE ISSUE ABOUT
AARP’S ONGOING CAMPAIGN AND
PRESCRIPTION DRUG PRICES CAN GO AARP’S ONGOING CAMPAIGN AND
PRESCRIPTION DRUG PRICES CAN GO
TO AARP .ORG. PRESCRIPTION DRUG PRICES CAN GO
TO AARP .ORG.
>> SO CRAZY WE TALK ABOUT TO AARP .ORG.
>> SO CRAZY WE TALK ABOUT
PRESCRIPTION DRUGS OVER >> SO CRAZY WE TALK ABOUT
PRESCRIPTION DRUGS OVER
$200,000 A YEAR. PRESCRIPTION DRUGS OVER
$200,000 A YEAR.
>> PEOPLE ARE MAKING HARD $200,000 A YEAR.
>> PEOPLE ARE MAKING HARD
CHOICES. >> PEOPLE ARE MAKING HARD
CHOICES.
A RECENT STUDY RELEASED THE 20 CHOICES.
A RECENT STUDY RELEASED THE 20
PERCENT OF PEOPLE AGES 19 TO 64 A RECENT STUDY RELEASED THE 20
PERCENT OF PEOPLE AGES 19 TO 64
ARE NOT TAKING THE PRESCRIPTION PERCENT OF PEOPLE AGES 19 TO 64
ARE NOT TAKING THE PRESCRIPTION
MEDICATIONS BECAUSE THEY JUST ARE NOT TAKING THE PRESCRIPTION
MEDICATIONS BECAUSE THEY JUST
CANNOT BE AFFORDED. MEDICATIONS BECAUSE THEY JUST
CANNOT BE AFFORDED.
>> YOU TO CONTINUE TO LOBBY CANNOT BE AFFORDED.
>> YOU TO CONTINUE TO LOBBY
LAWMAKERS AND TRY TO GET >> YOU TO CONTINUE TO LOBBY
LAWMAKERS AND TRY TO GET
ORGANIZATIONS LIKE AARP AND THE LAWMAKERS AND TRY TO GET
ORGANIZATIONS LIKE AARP AND THE
MIX TO TRY TO PUT PRESSURE TO ORGANIZATIONS LIKE AARP AND THE
MIX TO TRY TO PUT PRESSURE TO
GET SOME SORT OF CAP ON THESE MIX TO TRY TO PUT PRESSURE TO
GET SOME SORT OF CAP ON THESE
THINGS. GET SOME SORT OF CAP ON THESE
THINGS.
BECAUSE EVERYONE DOES NOT HAVE THINGS.
BECAUSE EVERYONE DOES NOT HAVE
TIME TO DO ALL THE EXTRA BECAUSE EVERYONE DOES NOT HAVE
TIME TO DO ALL THE EXTRA
HOMEWORK CALLING HERE AND GOING TIME TO DO ALL THE EXTRA
HOMEWORK CALLING HERE AND GOING
THERE TO TRY AND GET A LOWER HOMEWORK CALLING HERE AND GOING
THERE TO TRY AND GET A LOWER
PRICE. THERE TO TRY AND GET A LOWER
PRICE.
>> TO STAY HEALTHY AND STAY PRICE.
>> TO STAY HEALTHY AND STAY
ALIVE. >> TO STAY HEALTHY AND STAY
ALIVE.
>> KIRSTEN O’CONNOR HAS BEEN ALIVE.
>> KIRSTEN O’CONNOR HAS BEEN
WORKING ON STORIES ABOUT >> KIRSTEN O’CONNOR HAS BEEN
WORKING ON STORIES ABOUT
CHILDREN AND TEENAGERS GOING TO WORKING ON STORIES ABOUT
CHILDREN AND TEENAGERS GOING TO
WASHINGTON FOR THE INSULIN CHILDREN AND TEENAGERS GOING TO
WASHINGTON FOR THE INSULIN
PRICES AND SAYING IT IS CHEAPER

Leave a Reply

(*) Required, Your email will not be published